|
| Press Releases |
|
 |
|
| Wednesday, June 19, 2013 |
|
|
INC Research Leads Conversation on Clinical Innovation at DIA 2013 Annual Meeting |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, will be showcasing the latest advances in clinical trial innovation with an extensive presence at the DIA 2013 Annual Meeting from June 23-27 at the Boston Convention and Exhibition Center. more info >> |
|
|
INC Research Releases New White Paper on How Clinical Innovation Leads to Improved Predictability and Efficiency for Drug Development Programs |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced it has released a new white paper titled, "Clinical Process Innovations for New Drug Development: Aligning Clinical Trials with Development Needs." more info >> |
|
| Saturday, June 1, 2013 |
|
|
INC Research Promotes Medical and Oncology Expertise in Support of "Building Bridges to Conquer Cancer" Initiative at 2013 ASCO Annual Meeting |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, is attending the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 - June 4 in Chicago to discuss accelerating development in the quest to conquer cancer. more info >> |
|
| Thursday, May 16, 2013 |
|
|
INC Research Announces 2013 "Perspectives" Webinar Series |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced it will kick off its 2013 "Perspectives" webinar series June 18 with a session focused on clinical innovation. more info >> |
|
| Thursday, May 2, 2013 |
|
|
INC Research Rated "Top CRO" by Investigative Sites Globally |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, is ranked the "Top CRO" in the 2013 CenterWatch Global Investigative Site Relationship Survey. more info >> |
|
| Monday, March 11, 2013 |
|
|
INC Research Appoints James Taylor Vice President, Clinical Development |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced James Taylor has joined the Company as Vice President, Clinical Development. more info >> |
|
| Thursday, February 28, 2013 |
|
|
INC Research Names Garth Tierney Executive Vice President, Asia/Pacific |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the promotion of Garth Tierney to Executive Vice President, Asia/Pacific responsible for driving the strategic development and overall growth of the Company's Asia/Pacific clinical research operations. more info >> |
|
| Saturday, February 9, 2013 |
|
|
INC Research, LLC Fourth Quarter 2012 Results of Operations Release Date and Conference Call |
| INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, will conduct a conference call to discuss its fourth quarter 2012 financial results at 10:00 a.m. ET on Thursday, March 28, 2013. more info >> |
|
| Tuesday, January 8, 2013 |
|
|
Jamie Macdonald Assumes CEO Role at INC Research; Succession Plan Complete |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today reported the completion of its CEO succession plan announced in August 2012. more info >> |
|
| Friday, December 14, 2012 |
|
|
INC Research Reaches Major Trusted Process(R) Milestone with 500th QuickStart(R) Camp |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO), today announced it has reached a major milestone with its metrics-driven clinical trial outsourcing methodology known as the Trusted Process(R), completing its 500th QuickStart(R) Camp this week. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago
Apr 1, 2026 20:00 HKT/SGT
|
|
|
Four leading spring tech fairs will take place in April, featuring over 3,700 exhibitors
Apr 1, 2026 18:52 HKT/SGT
|
|
|
True IDC Pushes "Security Economy", Breaking Ground on Mega Data Center in EEC with 77-Billion-Baht BOI Investment, Cementing Thailand's No. 1 Position
Apr 1, 2026 18:50 HKT/SGT
|
|
|
China Risun (01907.HK) Reports Strong 37.7% Net Profit Surge in 2025 Amid Industry Challenges
Apr 1, 2026 18:07 HKT/SGT
|
|
|
中國旭陽集團（01907.HK）積極面對行業變化 2025年淨利逆勢增長37.7%
Apr 1, 2026 17:50 HKT/SGT
|
|
|
中国旭阳集团（01907.HK）积极面对行业变化 2025年净利逆势增长37.7%
Apr 1, 2026 17:42 HKT/SGT
|
|
|
CTF Life Collaborates with the HKMC to Refer the Policy Reverse Mortgage Programme and the Reverse Mortgage Programme
Apr 1, 2026 16:20 HKT/SGT
|
|
|
周大福人壽與香港按揭證券有限公司合作
Apr 1, 2026 16:02 HKT/SGT
|
|
|
Yuanda China's 2025 Operating Revenue Surged 27% to RMB 2.8 Billion, with a Net Profit of RMB 0.35 Billion, turning losses into gains
Apr 1, 2026 15:00 HKT/SGT
|
|
|
遠大中國2025年營收大增27%至28億元 淨利潤3.5億元扭虧為盈
Apr 1, 2026 13:10 HKT/SGT
|
|
|
远大中国2025年营收大增27%至28亿元 净利润3.5亿元扭亏为盈
Apr 1, 2026 13:04 HKT/SGT
|
|
|
芯智控股2025年淨利潤大增60.8%至1.61億港元 AI戰略驅動業績創新高
Apr 1, 2026 12:56 HKT/SGT
|
|
|
芯智控股2025年净利润大增60.8%至1.61亿港元 AI战略驱动业绩创新高
Apr 1, 2026 12:46 HKT/SGT
|
|
|
純利躍升超26倍！品創控股（8066.HK）2025年AI + 私域雙輪開啟增長新週期
Apr 1, 2026 12:37 HKT/SGT
|
|
|
MHI President Eisaku Ito Offers Words of Encouragement to New Employees at the Company's 2026 Welcoming Ceremony
Apr 1, 2026 13:35 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
